Missed Opportunities for Vaccine Equity
NCT04834960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900
Last updated 2022-10-06
Summary
Despite the overwhelming impact of vaccines on child health and the tremendous progress in vaccine coverage globally, challenges of vaccine inequities persist. Missed opportunities for vaccination (MOV) is defined as any contact with health services by an individual who is eligible for vaccination which does not result in the recommended vaccines being given. This is common in several countries, and it presents a window of opportunity to provide vaccine services to those vulnerable children accessing healthcare facilities.
The overall purpose of this project is to reduce missed opportunities for vaccinations by targeting hospitalized children who are vulnerable to poor health outcomes, but who are also within easy access of the healthcare system. The research team proposes implementing the Missed Opportunities for Vaccination Equity (MOVE), an intervention to improve timeliness and coverage of vaccination, and increase demand for vaccination services, through a combination of sensitization of children's caregivers and health workers, manual vaccination data capture in the ward, and re-purposed vaccination resources. The strategy engages key stakeholders in the design of the intervention through a co-creation workshop; their involvement in the design and execution of the intervention will improve sustainability in the long-term. This intervention builds on existing healthcare systems, and, when scaled up, can target inequities in vaccination coverage in the general population, without placing additional strain on the healthcare system in terms of workforce or financial resources.
Conditions
- Under-vaccinated
Interventions
- OTHER
-
Minimizing Missed Opportunities for Vaccination (MOV)
This bundle of interventions has four components that include: (1) Disseminate (vaccination awareness among healthcare providers and child caregivers); (2) Document (vaccination status); (3) Deploy (vaccines); and (4) Discharge (provide advice/referrals for catch-up and routine vaccinations).
Sponsors & Collaborators
-
Post Graduate Institute of Medical Education and Research, Chandigarh
collaborator OTHER -
Aminu Kano Teaching Hospital
collaborator OTHER -
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Anita Shet, MD, PhD · Johns Hopkins Bloomberg School of Public Health
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 0 Months
- Max Age
- 23 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-24
- Primary Completion
- 2021-09-16
- Completion
- 2021-09-16
Countries
- India
- Nigeria
Study Locations
More Related Trials
-
Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
NCT06616753 ·Status: RECRUITING
-
Improving Uptake of Pediatric Vaccines Through Religious Conferences and Vaccines-in-a-van in Aceh, Indonesia
NCT06160999 ·Status: COMPLETED ·Phase: NA
-
A Tool Kit to Improve Vaccine Confidence in the Philippines
NCT06218368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil
NCT06675721 ·Status: NOT_YET_RECRUITING
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Pertussis Immunization Programs in Low Income Countries - Ivory Coast
NCT03388034 ·Status: COMPLETED
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine
NCT00126217 ·Status: TERMINATED ·Phase: PHASE4
-
Trial of Additional Measles Vaccine to Reduce Child Mortality
NCT01644721 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839 ·Status: COMPLETED ·Phase: PHASE1
-
Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
NCT05042011 ·Status: UNKNOWN
-
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
NCT01830257 ·Status: UNKNOWN ·Phase: PHASE4
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria
NCT07154836 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Low Birth Weight Follow-up
NCT03020147 ·Status: COMPLETED
-
Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?
NCT00146302 ·Status: COMPLETED ·Phase: PHASE4
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region
NCT00600782 ·Status: COMPLETED ·Phase: PHASE2
-
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
NCT03145324 ·Status: COMPLETED
-
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 ·Status: COMPLETED ·Phase: NA
-
BCG Revaccination in Children and Adolescents
NCT05330884 ·Status: SUSPENDED ·Phase: PHASE3
-
Vaccination Coverage and Uptake in Young People Experiencing or at Risk of Homelessness
NCT04864678 ·Status: COMPLETED